Table 3.
Characteristics Associated with Discussing Clinical Trials with a Provider and Knowledge of Trial Availability Among 1264 Women with an Adolescent And Young Adult Cancer Diagnosis in North Carolina or Kaiser Permanente Southern California During 2004–2016
| Discussed trial with provider |
Knowledge of trial availability |
|||
|---|---|---|---|---|
| Unadjusted OR (95% CI) | Multivariable-adjusted OR (95% CI)a | Unadjusted OR (95% CI) | Multivariable-adjusted OR (95% CI)a | |
| Cancer typeb | ||||
| Breast | 1 | 1 | 1 | 1 |
| Lymphoma | 0.60 (0.41–0.88) | 0.56 (0.37–0.85) | 0.78 (0.58–1.05) | 0.70 (0.51–0.95) |
| Melanoma | 0.17 (0.09–0.32) | 0.16 (0.08–0.31) | 0.59 (0.44–0.81) | 0.55 (0.40–0.75) |
| Gynecologic | 0.27 (0.16–0.48) | 0.27 (0.15–0.47) | 0.67 (0.49–0.92) | 0.65 (0.48–0.89) |
| Thyroid | 0.09 (0.04–0.18) | 0.08 (0.04–0.17) | 0.46 (0.35–0.60) | 0.42 (0.32–0.56) |
| Age at diagnosisc | ||||
| 15–29 | 1 | 1 | 1 | 1 |
| 30–39 | 1.52 (1.10–2.10) | 0.86 (0.62–1.20) | 1.00 (0.81–1.22) | 0.78 (0.63–0.97) |
| Per year | 1.05 (1.02–1.07) | 1.00 (0.97–1.02) | 1.01 (0.99–1.03) | 0.99 (0.97–1.01) |
| Race/ethnicity | ||||
| Non-Hispanic White | 1 | 1 | 1 | 1 |
| Other | 0.83 (0.62–1.12) | 0.76 (0.58–1.01) | 1.14 (0.94–1.39) | 1.11 (0.91–1.35) |
| Hospital typed | ||||
| NCI cancer center | 1.21 (0.87–1.68) | 1.47 (1.09–1.99) | 1.40 (1.11–1.77) | 1.51 (1.20–1.90) |
| Academic, not NCI | 1.26 (0.84–1.89) | 1.16 (0.79–1.70) | 1.18 (0.86–1.62) | 1.13 (0.83–1.55) |
| Nonacademic | 1 | 1 | 1 | 1 |
| Residency programd | ||||
| No | 1 | 1 | 1 | 1 |
| Yes | 1.15 (0.87–1.54) | 1.18 (0.90–1.54) | 1.30 (1.04–1.61) | 1.30 (1.05–1.61) |
a
Adjusted for cancer type and age at diagnosis.
b
Adjusted estimates are adjusted for age at diagnosis only.
c
Adjusted estimates are adjusted for cancer type only.
d
Among those who received majority of their cancer care in North Carolina.
CI, confidence interval; OR, odds ratio.